Search results

3 items
  1. Yemen: Towards Qat Demand Reduction

    01 June 2007

    This report, based on a household survey conducted in 2006, discusses options for discouraging qat consumption in Yemen. It draws on a survey - the first representative data collection exercise aimed specifically at assessing the qat consumption phenomena - which confirms that the use of this drug is widespread. Qat is consumed by men, women and children; its use is extremely time consuming; it drains the family budget; has adverse health effects; negatively affects work performance and thus contributes to poverty.

     

  2. Should Khat Be Banned?

    • Degol Hailu, Policy Specialist, UNDP, Caribbean
    01 July 2007

    The global trade in khat is controversial. The United States and most countries in Europe have banned it, considering it a psychotropic substance. But it contributes significantly to farmers’ livelihood in Eastern Africa. Though public officials in the region denounce its consumption, they benefit from the foreign exchange and tax revenues that it generates. So, how should this contradiction be resolved?

     

  3. Ephedra for fun, performance and losing weight

    • Cas Barendregt, Brigitte Boon
    01 January 2007

    Substances that contain ephedra are known to aid weight loss and enhance athletic performance. Until April 2004 in the Netherlands, products containing this substance were available in pharmacies but also in so-called 'smart shops' (establishments where legal psychoactive substances are sold, usually for leisure purposes), where they were marketed as drugs for recreational use. On 6 April 2004, the Dutch government classified ephedra alkaloids as a medical drug in the Act on the Provision of Medical Drugs.